Clinical Trials in Mexico and LATAM
We run and rescue clinical trials across Mexico, Brazil, Colombia and Argentina. Local teams, local sites, one contract.
300+ sites · 10,500+ patients · 30+ studies · 0.7% lost to follow-up
Track record
Your clinical trials in Mexico, Argentina, Colombia and Brazil
Cohortias is a locally based, full-service CRO in Latin America. Local teams, local sites, one contract.
Sites throughout LATAM
Hospital and clinic sites in our contracted network.
Patients in our network
Reachable through our investigator network in four countries.
Studies conducted
Phase I to IV, interventional and observational.
Lost-to-follow-up rate
Measured across Cohortias studies.
Biotech, pharmaceutical and medical device sponsors work with Cohortias to add Latin American sites to a global program, or to run a study in the region from start to finish. Our regulatory teams file with COFEPRIS in Mexico, ANVISA in Brazil, INVIMA in Colombia and ANMAT in Argentina. Sites are selected, contracted and monitored by our own staff under ICH-GCP.
Sponsors
Companies that trust Cohortias
Pharma, biotech and academic sponsors, from single-country studies to multi-country programs. See the selected experience
Services
Clinical trial services in Mexico and LATAM
Four ways sponsors work with us. Every service runs from our own offices in Argentina, Brazil, Colombia and Mexico.
Early Phase Trials
- First-in-human studies
- Reach patients without an IND
- Data accepted in FDA submissions
Rescue Studies
- Recover enrollment on a study that is behind
- We work alongside the global CRO already in place
- More than 300 sites available
Phase II and III Trials
- Full-service clinical outsourcing
- Local regulatory teams in four countries
- Wide network of sites and investigators
Medical Devices
- Pilot and pivotal device studies
- Import and shipping handled locally
- From site selection to data collection
Outsourcing Clinical Trial Services
Clinical Research in Latin America
Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.
Why Latin America
Why sponsors run clinical trials in Latin America
Four reasons sponsors add Latin American sites to a program, and the capabilities we run once they do.
Patient concentration
Large urban hospitals concentrate patients, so a single site can enroll more than its equivalent in the United States or Europe.
Lower operating costs
Labor, vendors, utilities and equipment cost less in the region. The same protocol runs on a smaller budget.
Two languages, four countries
Spanish and Portuguese cover Mexico, Colombia, Argentina and Brazil. Fewer translations and faster start-up.
Access to growing markets
Running a trial in the region builds relationships with investigators and regulators before a product launch.
Clinical development
End-to-end support for Phase I to IV, from planning and start-up through monitoring and close-out.
- Site selection
- Site management
- Regulatory submissions
- Clinical monitoring
- Data management
- Protocol development
- Patient recruitment
- Study start-up
Main therapeutic areas
Experience across the areas sponsors most often bring to the region.
See studies by countryCohortiasadds valueto your business
Local teams, local sites, one contract. We run and rescue trials across Mexico, Colombia, Brazil and Argentina.
Academic Leadership
- Our peer-to-peer management approach drives high patient recruitment and retention in any clinical trial.
- An extensive clinical site network across our four countries.
High Speed Execution
- We offer the quickest start-up times in each country.
- Efficient clinical site selection and contracting.
Operational Excellence
- Proven record of delivering rescue studies, consistently exceeding industry performance standards.
- Efficient query resolution keeps your trial on track.
Business Insight and Flexibility
- Innovative pricing models and short lines of communication.
- Swift adaptation to changes in the trial landscape to keep your study on schedule.
Offices in 4 countries
Local CRO in Latin America
Cohortias runs clinical trials from local offices in Argentina, Brazil, Colombia and Mexico. Local teams, local sites, one contract.
Mexico
Clinical trials in MexicoBrazil
Clinical trials in BrazilColombia
Clinical trials in ColombiaArgentina
Clinical trials in Argentina
Have a general question?
Step 1 of 3Prefer email? info@cohortias.com
Inside Cohortias
Academic leadership, local teams, one contract
Physicians manage physicians. That peer-to-peer approach is what keeps recruitment and retention high in our studies.
Years in clinical research
Phase I to IV programs run in Latin America by the same core team.
Local offices
Argentina, Brazil, Colombia and Mexico. No third party between you and the site.
Local regulatory teams
Submissions prepared and filed by staff based in each country.
Contract
One agreement and one point of contact for all four countries.
FAQ
Clinical trials in Mexico and LATAM, answered
Short answers to what sponsors ask us first. Anything else, our regional team replies the same week.
What does Cohortias do as a CRO in Latin America?
Cohortias is a full-service contract research organization based in Latin America. We run clinical trials from our own offices in Argentina, Brazil, Colombia and Mexico, covering regulatory submissions, site selection, site contracting, clinical monitoring and data management. Sponsors sign one contract for all four countries.
Which countries and regulators does Cohortias cover?
Mexico with COFEPRIS, Brazil with ANVISA, Colombia with INVIMA and Argentina with ANMAT. There is a local team in each country, and every submission is prepared and filed by staff based there.
Can Cohortias rescue a study that is behind on enrollment?
Yes. Rescue work is one of our main services. We add Latin American sites to a protocol that is already running and work alongside the global CRO in place, activating sites from a network of more than 300. The lost-to-follow-up rate across our studies is 0.7%.
What trial phases and study types do you run?
Phase I to Phase IV, including first-in-human studies, interventional and observational programs, and pilot and pivotal medical device studies. We have conducted more than 30 studies in the region.
How does the Cohortias partnering model work?
One contract with Cohortias covers all four countries. The sponsor keeps a single point of contact and short lines of communication, while our local teams handle regulatory, sites and monitoring in each country. Pricing is agreed per program rather than from a fixed rate card.
How much experience does the Cohortias team have?
More than 20 years of clinical research in Latin America, including Phase III outcome trials such as AleCardio and the SPIRE program, both run across our four countries. Study and patient numbers by country are published on our track record page.
Planning a study in Latin America?
Tell us about your program and target countries. Our regional team will follow up with next steps.